Case number 1:23-cv-00179
Novo Nordisk Inc. et al v. Orbicular Pharmaceutical Technologies Pvt. Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 22, 2023 | N/A | Case associated with lead case: Create association to 1:22-cv-00856-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 22-856-CFC ONLY. (nmf) (Entered: 05/22/2023) (0) |
| May 22, 2023 | 26 | ORDER granting (85) Motion to Consolidate Cases in case 1:22-cv-00856-CFC; granting (25) Motion to Consolidate Cases in case 1:23-cv-00179-CFC. These actions are consolidated for all purposes, and all papers shall be filed in Lead Case No. 22-856-CFC. Signed by Judge Colm F. Connolly on 5/22/2023. (nmf) (Entered: 05/22/2023) (2) |
| May 19, 2023 | 25 | Joint MOTION to Consolidate Cases (Case No. 23-179-CFC into Lead Case No. 22-856-CFC) - filed by Novo Nordisk A/S. (Murray, Travis) (Entered: 05/19/2023) (6) |
| May 19, 2023 | 24 | Letter to The Honorable Colm F. Connolly from Travis Murray regarding Motion to Consolidate and the Court's March 14, 2023 Order in C.A. 23-179. (Murray, Travis) (Entered: 05/19/2023) (3) |
| May 19, 2023 | 23 | SO ORDERED, re 22 STIPULATION TO EXTEND TIME to submit a proposed order for discovery of electronically-stored information ("ESI Order") and a proposed Protective Order to May 25, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 5/19/2023. (kmd) (Entered: 05/19/2023) (3) |
| May 18, 2023 | 22 | STIPULATION TO EXTEND TIME to submit a proposed order for discovery of electronically-stored information ("ESI Order") and a proposed Protective Order to May 25, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 05/18/2023) (3) |
| May 4, 2023 | 20 | NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and (2) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 05/04/2023) (5) |
| May 4, 2023 | 21 | NOTICE OF SERVICE of Defendant Orbicular Pharmaceutical Technology Pvt. Ltd.'s (1) Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and (2) Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Orbicular Pharmaceutical Technologies Pvt. Ltd..(Haynes, Christine) (Entered: 05/04/2023) (2) |
| May 1, 2023 | 19 | NOTICE OF SERVICE of Plaintiffs' Preliminary Disclosure of Asserted Claims - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 05/01/2023) (4) |
| Apr 27, 2023 | 18 | SCHEDULING ORDER: Joinder of Parties due by 5/24/2024. Amended Pleadings due by 5/24/2024. Fact Discovery completed by 6/28/2024. Expert Discovery due by 10/22/2024. Joint Claim Construction Brief due by 11/8/2023. A Markman Hearing is set for 12/13/2023 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 1/7/2025. A Final Pretrial Conference is set for 1/28/2025 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 2/3/2025 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 4/27/2023. (nmf) (Entered: 04/27/2023) (30) |
| Apr 24, 2023 | 17 | Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding case coordination - re 11 Order,,, Set Deadlines,, SO ORDERED,, Set Deadlines,. (Attachments: # 1 Proposed Scheduling Order)(Egan, Brian) (Entered: 04/24/2023) (Proposed Scheduling Order) (30) |
| Apr 24, 2023 | 17 | Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding case coordination - re 11 Order,,, Set Deadlines,, SO ORDERED,, Set Deadlines,. (Attachments: # 1 Proposed Scheduling Order)(Egan, Brian) (Entered: 04/24/2023) (Main Document) (2) |
| Apr 18, 2023 | N/A | SO ORDERED, re 16 STIPULATION TO EXTEND TIME to submit a proposed scheduling order to April 24, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc. Resetting Deadlines: Notice of Compliance deadline set for 4/24/2023.Ordered by Judge Colm F. Connolly on 4/18/2023. (kmd) (Entered: 04/18/2023) (0) |
| Apr 17, 2023 | 16 | STIPULATION TO EXTEND TIME to submit a proposed scheduling order to April 24, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 04/17/2023) (2) |
| Apr 14, 2023 | N/A | Pro Hac Vice Attorneys William R. Zimmerman, William O. Adams, and Aryeh N. Feinstein for Orbicular Pharmaceutical Technologies Pvt. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) (Entered: 04/14/2023) (0) |
| Apr 6, 2023 | N/A | SO ORDERED, re 15 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter and Olivia L. Wheeling, filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 4/6/2023. (kmd) (Entered: 04/06/2023) (0) |
| Apr 6, 2023 | 15 | MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter and Olivia L. Wheeling - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 04/06/2023) (11) |
| Apr 5, 2023 | 14 | NOTICE of Appearance by Christine Dealy Haynes on behalf of Orbicular Pharmaceutical Technologies Pvt. Ltd. (Haynes, Christine) (Entered: 04/05/2023) (1) |
| Apr 4, 2023 | 13 | ANSWER to 9 Answer to Complaint, Counterclaim - by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 04/04/2023) (10) |
| Mar 16, 2023 | N/A | SO ORDERED, re 12 MOTION for Pro Hac Vice Appearance of Attorney Nicholas A. Belair, Karen M. Cassidy Selvaggio, Joseph M. Reisman, Ph.D., William R. Zimmerman, Aryeh N. Feinstein and William O. Adams, filed by Orbicular Pharmaceutical Technologies Pvt. Ltd. Ordered by Judge Colm F. Connolly on 3/16/2023. (kmd) (Entered: 03/16/2023) (0) |
| Mar 15, 2023 | 12 | MOTION for Pro Hac Vice Appearance of Attorney Nicholas A. Belair, Karen M. Cassidy Selvaggio, Joseph M. Reisman, Ph.D., William R. Zimmerman, Aryeh N. Feinstein and William O. Adams - filed by Orbicular Pharmaceutical Technologies Pvt. Ltd.. (Farnan, Kelly) (Entered: 03/15/2023) (8) |
| Mar 14, 2023 | 9 | ANSWER to 1 Complaint, , COUNTERCLAIM against Novo Nordisk A/S, Novo Nordisk Inc. by Orbicular Pharmaceutical Technologies Pvt. Ltd..(Farnan, Kelly) (Entered: 03/14/2023) (19) |
| Mar 14, 2023 | 10 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Orbicular Pharmaceutical Technologies Pvt. Ltd.. (Farnan, Kelly) (Entered: 03/14/2023) (2) |
| Mar 14, 2023 | 11 | ORDER, having been assigned these cases which are listed as related to earlier filed cases that are currently proceeding on an agreed upon schedule entered by the Court; IT IS ORDERED that, on or before April 17, 2023, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed.ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 4/17/2023.) Signed by Judge Colm F. Connolly on 3/14/2023. Associated Cases: 1:23-cv-00101-CFC, 1:23-cv-00179-CFC(nmf) (Entered: 03/14/2023) (2) |
| Feb 24, 2023 | 8 | STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) (Entered: 02/24/2023) (2) |
| Feb 22, 2023 | 7 | AFFIDAVIT of Service for Summons, Complaint and related papers served on Orbicular Pharmaceutical Technologies Pvt. Ltd. c/o Joseph Reisman on February 21, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) (Entered: 02/22/2023) (10) |
| Feb 22, 2023 | N/A | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) (Entered: 02/22/2023) (0) |
| Feb 17, 2023 | 1 | COMPLAINT filed with Jury Demand against Orbicular Pharmaceutical Technologies Pvt. Ltd. ( Filing fee $ 402, receipt number ADEDC-4069694.) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(mpb) (Entered: 02/17/2023) (Main Document) (7) |
| Feb 17, 2023 | 6 | Summons Issued as to Orbicular Pharmaceutical Technologies Pvt. Ltd. on 2/17/2023. (mpb) (Entered: 02/17/2023) (2) |
| Feb 17, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk A/S, Corporate Parent Novo Nordisk US Holdings Inc., Corporate Parent Novo Nordisk Commercial Holdings, Inc. for Novo Nordisk Inc.; Corporate Parent Novo Nordisk Foundation for Novo Nordisk A/S filed by Novo Nordisk A/S, Novo Nordisk Inc.. (mpb) (Entered: 02/17/2023) (2) |
| Feb 17, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,114,833 B2 ;9,265,893 B2. (mpb) (Entered: 02/17/2023) (1) |
| Feb 17, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/5/2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 7/5/2025. (mpb) (Entered: 02/17/2023) (1) |
| Feb 17, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 02/17/2023) (3) |
| Feb 17, 2023 | 1 | COMPLAINT filed with Jury Demand against Orbicular Pharmaceutical Technologies Pvt. Ltd. ( Filing fee $ 402, receipt number ADEDC-4069694.) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(mpb) (Entered: 02/17/2023) (Exhibit A-B) (30) |
| Feb 17, 2023 | 1 | COMPLAINT filed with Jury Demand against Orbicular Pharmaceutical Technologies Pvt. Ltd. ( Filing fee $ 402, receipt number ADEDC-4069694.) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(mpb) (Entered: 02/17/2023) (Civil Cover Sheet) (2) |
